Cargando…

Neural network analysis in pharmacogenetics of mood disorders

BACKGROUND: The increasing number of available genotypes for genetic studies in humans requires more advanced techniques of analysis. We previously reported significant univariate associations between gene polymorphisms and antidepressant response in mood disorders. However the combined analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serretti, Alessandro, Smeraldi, Enrico
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539307/ https://www.ncbi.nlm.nih.gov/pubmed/15588300 http://dx.doi.org/10.1186/1471-2350-5-27

Ejemplares similares

Influence of postpartum onset on the course of mood disorders
por: Serretti, Alessandro, et al.
Publicado: (2006)

Pharmacogenetics and Depression: A Critical Perspective
por: Corponi, Filippo, et al.
Publicado: (2019)

Pharmacogenetics of antidepressant response: An update
por: Drago, Antonio, et al.
Publicado: (2009)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality
por: Olgiati, Paolo, et al.
Publicado: (2023)

Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

Seasonality and Sleep: A Clinical Study on Euthymic Mood Disorder Patients
por: Brambilla, Chiara, et al.
Publicado: (2012)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Neural Plasticity in Mood Disorders
por: Hall, F. Scott, et al.
Publicado: (2018)

Possible Modulatory Role of ARC Gene Variants in Mood Disorders
por: Crisafulli, Concetta, et al.
Publicado: (2021)

The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018)

Pharmacogenetics in Primary Headache Disorders
por: Belyaeva, Irina I., et al.
Publicado: (2022)

Anhedonia and Depressive Disorders
por: Serretti, Alessandro
Publicado: (2023)

PM449. Hot genes in schizophrenia: case-control, pharmacogenetics and exploratory analyses in two independent samples
por: Porcelli, Stefano, et al.
Publicado: (2016)

Alterations of neural network organization during REM sleep in women: implication for sex differences in vulnerability to mood disorders
por: Hein, Matthieu, et al.
Publicado: (2020)

Clinical Utility of Fluid Biomarker in Depressive Disorder
por: Serretti, Alessandro
Publicado: (2022)

Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
por: Seeberg, Ida, et al.
Publicado: (2018)

LITHIUM IN THE TREATMENT OF BIPOLAR DISORDER: PHARMACOLOGY AND PHARMACOGENETICS
por: Alda, Martin
Publicado: (2015)

Predicting the risk and timing of major mood disorder in offspring of bipolar parents: exploring the utility of a neural network approach
por: Cooper, Alysha, et al.
Publicado: (2021)

The Genetic Side of the Mood: A Scientometric Review of the Genetic Basis of Mood Disorders
por: Bonacina, Giovanni, et al.
Publicado: (2023)

Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2021)

RNA Editing and Modifications in Mood Disorders
por: Barbon, Alessandro, et al.
Publicado: (2020)

Disorders of mood

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

Neuroplasticity in mood disorders
por: Drevets, Wayne C.
Publicado: (2004)

Optogenetic Dissection of Neural Circuits Underlying Stress-Induced Mood Disorders
por: Liu, Qing, et al.
Publicado: (2021)

Altered Functional Connectivity of Salience Network in Mood Disorders
por: Todeva-Radneva, A., et al.
Publicado: (2023)

Different Neural Responses to a Moral Valence Decision Task in Unipolar and Bipolar Depression
por: Radaelli, Daniele, et al.
Publicado: (2013)

ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
por: Calabrò, Marco, et al.
Publicado: (2020)

Postpartum Mood Disorders and Thyroid Autoimmunity
por: Le Donne, Maria, et al.
Publicado: (2017)

Psychotherapy of Mood Disorders
por: Picardi, Angelo, et al.
Publicado: (2014)

Facial expression (mood) recognition from facial images using committee neural networks
por: Kulkarni, Saket S, et al.
Publicado: (2009)

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020)

Pharmacogenetics in the clinic
por: Guchelaar, H.-J.
Publicado: (2013)

A brief review of the genetics and pharmacogenetics of opioid use disorders
por: Berrettini, Wade
Publicado: (2017)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

Pharmacogenetics of Cannabinoids
por: Hryhorowicz, Szymon, et al.
Publicado: (2017)

Pharmacogenetic And Tumour Drugs
por: Topic, Elizabeta
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_kqjadh9mr96u1379akohs4j26g